Permanente Medicine
MAY 20, 2025
” Related AI scribes story: Analysis: AI scribes save physicians time, improve patient interactions and work satisfaction Dr. Nguyen also highlighted the potential to utilize artificial intelligence and Kaiser Permanente’s extensive medical database to develop predictive analytic models aimed at enhancing patient care.
The Medical Futurist
JUNE 21, 2025
4) Cureskin The artificial intelligence-based app was developed by two engineers previously working for Google , and it aims to compensate for the lack of dermatologists in India. (*There are widely varying figures, ranging from 66% to 90% depending on the source of information.) Cureskin aims to help alleviate the situation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
JUNE 16, 2025
The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Food and Drug Administration (FDA). The process could take years. Ibogaine is made from the root of a plant found in Africa. It has been banned in the U.S. Former Texas Gov.
Medical Xpress
JUNE 16, 2025
This cluster of about 20,000 to 40,000 neurons functions like a central watch, coordinating the timing of body functions to follow the 24-hour day. When we cross time zones and experience jet lag, it happens because our internal clock remains set to the old time zone. But the NTU team discovered that it is far more complex.
Physician's Weekly
JUNE 23, 2025
Jessica Conard , another resident, said her son developed asthma after breathing in toxic fumes. Andrew Whelton , a civil and environmental engineer at Purdue University who works with communities affected by disasters, said the money is necessary — and should have come sooner.
Medical Xpress
JUNE 8, 2025
Sucrose is thought to activate centers of the brain that modulate pain and lead to the release of endorphins , but the exact mechanism remains unclear. It has become the worldwide standard of care for acute neonatal pain, but it doesnt seem to be helping in the long term. Read the original article. Your feedback is important to us.
Medical Xpress
JUNE 7, 2025
None of the participants who received the injections got HIV. That early success helped boost Gileads stock by 73% over the past year, The Wall Street Journal reported. "We We know its challenging to take a daily pill for prevention, and we see an incredible opportunity here," Johanna Mercier, Gileads chief commercial officer, said.
Expert insights. Personalized for you.
52 
Let's personalize your content